Published trade mark details for 2506247
This information was published on 2025-02-24T08:22:12 for IP Right Registration Published.
| Field | Value |
| (210) | 2506247 (IR 1827805) |
| (220) |
15 Oct 2024
|
| (300) |
CA, 12 Jul 2024, 2338225
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical preparations; medicines for human purposes; diagnostic preparations for medical purposes; chemical preparations for pharmaceutical and medical purposes; biological preparations for medical purposes; therapeutic preparations, prophylactic preparations, and pharmaceutical products and agents for the treatment or prophylaxis of human diseases, disorders and conditions, namely, cancer, autoimmune and inflammatory diseases. Class 42 Chemical, biochemical and biological research and analysis; biotechnological research and development; medical and pharmacological research and development services; pharmaceutical product development and evaluation; conducting clinical trials for pharmaceutical products; scientific research and development of preparations, agents and technology for the development of antibody therapeutics for the treatment, and prophylaxis of human diseases, disorders and conditions, namely, cancer, auto immune and inflammatory diseases; providing scientific information to scientists, physicians and health care providers in the field of cancer, auto immune diseases, inflammatory diseases, and infectious diseases; chemical molecular analysis and product optimization services provided to pharmaceutical, biotechnology and chemical industries using proprietary software and proprietary analytical tools and algorithms. Class 45 Intellectual property licensing services. |
| (540) |
|
| (550) | Figurative |
| (730) |
Zymeworks BC Inc.
|
Find out more about publications on the About page.